Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation

被引:41
作者
Gangadhar, Katkam N. [3 ]
Adhikari, Kajiram [1 ]
Srichana, Teerapol [1 ,2 ]
机构
[1] Prince Songkla Univ, Drug Delivery Syst Excellence Ctr, Dept Pharmaceut Technol, Fac Pharmaceut Sci, Hat Yai 90112, Songkhla, Thailand
[2] Prince Songkla Univ, Nanotec PSU Excellence Ctr Drug Delivery Syst, Dept Pharmaceut Technol, Fac Pharmaceut Sci, Hat Yai 90112, Songkhla, Thailand
[3] Univ Nova Lisboa, Inst Chem & Biol Technol, Lisbon, Portugal
关键词
Amphotericin B; SDS-AmB; Fungizone (R); Zeta potential; Toxicities; Aerosol; IN-VITRO; CRYPTOCOCCUS-NEOFORMANS; ANTIFUNGAL ACTIVITY; NATIONAL COMMITTEE; AGGREGATION STATE; TOXICITY; SUSCEPTIBILITY; DELIVERY; VIVO; ASPERGILLOSIS;
D O I
10.1016/j.ijpharm.2014.05.066
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Amphotericin B (AmB) is still used as the gold standard for therapy against invasive fungal diseases. However, the use of AmB through oral administration is restricted due to its low solubility and stability in aqueous solution, which is the cause for its poor bioavailability and highly varying absorption. Therefore, an attempt has been made to enhance the solubility and stability of AmB to evaluate its bioactivity and safety for use as an inhaler by using a new excipient sodium deoxycholate sulfate (SDS) with aim of using it as a drug carrier for AmB. Therefore, SDS was formulated together with AmB as a dry powder by lyophilization. The dry powder was reconstituted in distilled water and evaluated its physicochemical properties such as zeta potential, particle size and pH to compare its solubility and stability of the formulations with a SDC-AmB (i.e., known as Fungizone (R)). In vitro toxicity studies were carried out with red blood cells (RBC) and respiratory cell lines. Bioactivity was determined by a micro-dilution method against Candida albicans and Cryptococcus neoformans. We found that SDS-AmB had a zeta potential (-45.53 mV), which was higher than of Fungizone (R); and produced a stable particle size in solution (73.8 nm). The particle size distributions of both formulations were expressed as their mass median aerodynamic diameters (MMAD; 1.70 and 1.74 mu m), their fine particle fractions (FPF; 70 and 80%) and geometric standard deviations (GSD; 2.3 and 2.0), respectively. These values indicated that the sizes were appropriate for use in an inhaler. Pure AmB was found to hemolyse RBC and was very toxic to alveolar macrophage cells, as their viability rapidly declined from 93 to 56% when the AmB concentration increased from 1 to 8 mu g/mL. The SDS-AmB formulation had a significantly reduced toxicity compared to AmB. The results clearly indicated that the SDS-lipid based nanoparticles had the potential to be used as an alternative option to Fungizone (R) for an AmB formulation for inhalation. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:430 / 438
页数:9
相关论文
共 57 条
[1]   Amphotericin B lipid preparations: what are the differences? [J].
Adler-Moore, J. P. ;
Proffitt, R. T. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 :25-36
[2]  
AHFS, 2009, DRUG INF, P542
[3]   Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents [J].
Aller, AI ;
Martín-Mazuelos, E ;
Gutiérrez, MJ ;
Bernal, S ;
Chávez, N ;
Recio, FJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :997-1000
[4]   Antifungal susceptibilities of Cryptococcus neoformans [J].
Archibald, LK ;
Tuohy, MJ ;
Wilson, DA ;
Nwanyanwu, O ;
Kazembe, PN ;
Tansuphasawadikul, S ;
Eampokalap, B ;
Chaovavanich, A ;
Reller, LB ;
Jarvis, WR ;
Hall, GS ;
Procop, GW .
EMERGING INFECTIOUS DISEASES, 2004, 10 (01) :143-145
[5]  
Arnold Tamra M, 2010, Proc Am Thorac Soc, V7, P222, DOI 10.1513/pats.200906-048AL
[6]   Amphotericin B and Its New Derivatives - Mode of Action [J].
Baginski, M. ;
Czub, J. .
CURRENT DRUG METABOLISM, 2009, 10 (05) :459-469
[7]   EFFECTS OF THE AGGREGATION STATE OF AMPHOTERICIN-B ON ITS TOXICITY TO MICE [J].
BARWICZ, J ;
CHRISTIAN, S ;
GRUDA, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) :2310-2315
[8]  
Bennet JE., 1996, GOODMAN MIDGILMANS P, V9th, P1175
[9]   Synthesis and olfactory activity of unnatural, sulfated 5β-bile acid derivatives in the sea lamprey (Petromyzon marinus) [J].
Burns, Aaron C. ;
Sorensen, Peter W. ;
Hoye, Thomas R. .
STEROIDS, 2011, 76 (03) :291-300
[10]   Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans [J].
Chudzik, Barbara ;
Tracz, Izabela B. ;
Czernel, Grzegorz ;
Fiolka, Marta J. ;
Borsuk, Grzegorz ;
Gagos, Mariusz .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 49 (05) :850-857